¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
F.D.A. Approves Remdesivir for Patients Not Hospitalizednews2022-01-22T16:58:04+00:00January 22nd, 2022|The New York Times|
Searching for Pfizer’s Paxlovid Pills When Mom Got Covidnews2022-01-19T15:29:38+00:00January 19th, 2022|The New York Times|
Covid Treatments Including Paxlovid Are Rationed as Cases Spikenews2022-01-06T22:11:24+00:00January 6th, 2022|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adultsnews2021-12-24T02:19:46+00:00December 24th, 2021|The New York Times|
F.D.A. Clears Pfizer’s Covid Pill for High-Risk Patients 12 and Oldernews2021-12-22T22:02:31+00:00December 22nd, 2021|The New York Times|
Novavax’s Covid Vaccine Is Authorized in Europenews2021-12-21T04:57:33+00:00December 21st, 2021|The New York Times|